Related Experiment Video

Updated: Aug 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Treatment of dyslipidemia in chronic kidney disease

V Stefanovic1, M Milojkovic

  • 1Institute of Nephrology and Hemodialysis, Faculty of Medicine, Nis - Serbia. stefan@ni.ac.yu

The International Journal of Artificial Organs
|November 25, 2004
PubMed

Insights

Dyslipidemia in renal disease accelerates cardiovascular risks. While treatments exist, more long-term studies are needed to confirm reduced mortality in chronic kidney disease patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Disorders

Background:

  • Dyslipidemia is prevalent in renal diseases, contributing to atherosclerosis and cardiovascular complications.
  • Cardiovascular morbidity and mortality are significantly increased in patients with chronic kidney disease and end-stage renal disease (ESRD).
  • Managing dyslipidemia alongside blood pressure and proteinuria is crucial for retarding chronic renal insufficiency progression.

Purpose of the Study:

  • To review therapeutic strategies for dyslipidemia in renal patients.
  • To evaluate the effectiveness of current interventions in reducing cardiovascular risks in ESRD patients.

Main Methods:

  • Literature review of therapeutic approaches for dyslipidemia in renal disease.
  • Analysis of evidence for lipid-lowering interventions in chronic kidney disease and ESRD.
  • Assessment of the impact of statin therapy on atherogenesis.

Main Results:

  • Dietary modifications, dialysis techniques, and lipid-lowering drugs are potential treatments.
  • Statin therapy may inhibit atherogenesis even with normal lipid profiles.
  • Current interventions lack robust long-term data proving reduced cardiovascular mortality in ESRD.

Conclusions:

  • Effective management of dyslipidemia is essential for renal patients.
  • Further long-term prospective studies are required to establish optimal therapeutic strategies for high-risk ESRD populations.
  • Reducing cardiovascular risk in ESRD patients through lipid management requires more conclusive evidence.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...